GlaxoSmithKline (GSK) and Will Biotechnology have signed a $ 1 billion contract with the U.S. government on the 17th for a new coronavirus drug, sotrovimab,
GlaxoSmithKline (GSK) and Will Biotechnology have signed a $ 1 billion contract with the U.S. government on the 17th for a new coronavirus drug, sotrovimab,